Source: Eur Respir J 2007; 30: 722-728
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Janssens J-P., Roux-Lombard P., Perneger T., Metzger M., Vivien R., Rochat T.. Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis. Eur Respir J 2007; 30: 722-728

Member's Comments

No comment yet.

Related content which might interest you: Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Time interval to conversion of interferon-? release assay after exposure to tuberculosis Source: Eur Respir J 2011; 37: 1447-1452 Year: 2011 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010 Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Source: Eur Respir J 2011; 38: 649-656 Year: 2011 Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection Source: Eur Respir J 2012; 40: 1450-1457 Year: 2012 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Interferon-γ release assay tests to rule out active tuberculosis Source: Eur Respir J 2007; 30: 183-184 Year: 2007 Indeterminate test results of T-SPOTTM.TB performed under routine field conditions Source: Eur Respir J 2008; 31: 842-846 Year: 2008 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019